Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value
Stock: DXCM
Book Value Per Share: $5.78
EPS: $2.29
Diluted EPS TTM: $1.35
Dividend Per Share: None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Price To Sales Ratio TTM: 8.02
Price To Book Ratio: 14.49
PEG Ratio: 1.293
EV To EBITDA: 33.56
P/E Ratio: 62.87
Forward P/E Ratio: 41.84
Ex Dividend Date: None
Dividend Date: None
Current Price: $84.78
Previous Close: $85.33
52 Week Low: $57.52
52 Week High: $117.19
Earning Date (within 30 days): 2025-07-23
50 Day MA: $83.06
200 Day MA: $77.65
Link to Yahoo (Financial): DXCM

Advertisement
 
* Note: Prices are in Million (M) USD.
Description:
DexCom Inc (DXCM) ↓
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $606 M
Debt : $1,237 M
EBITDA : $858 M
Net Debt (Debt - Cash): $631 M

Since Net Debt is covered by EBITDA within 1 year, 3 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Diagnostics & Research

Based on industry, 3 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 37.02

Since Forward PE Ratio is greater than 35, 0 point assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $319 M
Average Revenue: $992 M
Revenue Converted To Free Cash FLow(%): 32%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 117.56%

Since Free Cash Flow (FCF) to Revenue percentage is greater than 25, 5 points assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $4,033 M
Revenue 4 Years Ago (2020-12-31): $1,927 M
Last 5 Years Average Revenue Growth: 22%

Since Revenue Growth is greater than 20, 5 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $413 M
Share Count 5 Years Ago (2020-12-31): $390 M

Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $2.61
Trailing 12-Month Earnings Per Share (EPS): $1.97
Average Earnings Per Share (EPS): $2.29
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -56%

Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $85
52-Week Low: $58
Threshold Price (15% Above 52-Week Low): $66

Since Current price is not within 15% threshold, 0 point assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $33,278 M

Since Market Cap is between 10B - 100B, 2 points assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 3% exposure of Total Portfolio.
Value-Trade has assigned 18 points to above DexCom Inc (DXCM) stock.
Last 8 Years Avg PE (Limited to last 8 years of EPS data) 40, Fair Value PE 12, Industry Based PE is 25 and Growth based PE is 15. Based on these all values average assigned is 23.00.
Value-Trades has assined P/E value 23.00. Since an average (Current Year EPS + Next Year EPS) earning per share is $2.29.
The fair value of DexCom Inc (DXCM) stock should be (23.00 x $2.29) = $52.67

Share this valuation:



Advertisement

Advertisement